RespireRx Pharmaceuticals Inc. RSPI

Full chart Compare
Set alert

Price alert · RSPI

All alert types
0.00 USD 0.00 (+0.00%)

At closeDec 15, 2025, 4:00 PM EST

0.0014 Day range 0.0018
0.0001 52-week range 0.0027
YTD
0.00%
1 year
+125.00%

Revenue & Expenses

Other Income → Expenses: $180.42KExpenses → Selling, General & Admin: $3.62MExpenses → Research & Development: $1.71MExpenses → Interest Expense: $902.70KGross Profit → Expenses: $86.92KRevenue → Gross Profit: $86.92KNet Loss → Expenses: $5.96MOther Income$180.42KGross Profit$86.92KNet Loss$5.96MExpenses$6.23MSelling, General & Admin$3.62MResearch & Development$1.71MInterest Expense$902.70KRevenue$86.92K

Latest period ending Dec 31, 2021 · select a line to chart its full history

RSPI annual income statement
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
-2.56M-3.32M-1.74M-2.18M-4.25M
-3.14M-4.30M-2.12M-2.59M-4.29M
-0.04-0.22-5.41-7.70-17.70
RSPI annual balance sheet
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
1.40K82516.69K33.28K84.90K
208.74K85.09K45.33K124.19K194.77K
10.22M8.15M7.49M5.86M4.55M
2.08M1.68M1.63M1.25M1.15M
-10.01M-8.06M-7.44M-5.73M-4.36M
RSPI annual cash flow
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
-956.17K-513.00K-487.75K-427.37K-697.01K
956.75K497.14K471.15K375.75K689.87K
573-15.87K-16.59K-51.62K-7.14K